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Abstract
Treatment of patients with chronic diseases will be one of the main challenges of medicine in the future. This
paper presents an overview of different origins, mechanism, and symptoms necessary for understanding new and
different interventions that include a psychosomatic view.
In a psychosomatic therapeutic intervention there are very different targets, such as psychological symptoms,
personality traits, attitudes toward disease and life, risk behaviour, and social isolation and as biological targets the
change of autonomic imbalance and of the effects of the psycho-endocrinological or psycho-immunological stress
responses. And there are also different psychosomatic measures that influence the individual biological,
psychological and sociological targets. There is a need to give different answer to different questions in the field of
psychosomatic and behavioral medicine. Comparative effectiveness research is an important strategy for solving
some methodological issues. What is the target of treatment for different diseases: Symptom reduction, healing, or
limiting progression to the worst case - the death of patients. We know that, the patient-physician relationship is
important for every medical/therapeutic action for patients with chronic diseases.
This volume of BioPsychoSocial Medicine will present four different psychosomatic treatment studies from the
clinical field in the sense of phase 2 studies: Reports of patients with obesity, anorexia nervosa, chronic somatoform
pain and coronary artery disease were presented
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Bio psycho social medicine integrates different levels of
research: The basic sciences focus on psychobiological
mechanisms (e.g. psycho-neuroendocrinology, psycho-
neuroimmunology, psycho-physiology) and psycho-
somatic correlations. Various pathways have been formu-
lated for different chronic diseases as have strategies for
research on interactions between psychic phenomenon
and biological functions found in different regions of the
body, such as the brain-gut axis and the brain-heart axis.
Medicine is not only a diagnostic discipline, but also a
research field for medical practice - concentrating on
physicians and other health care workers in action with
their patients and focusing on the transfer of psychoso-
matic knowledge gained in the clinical practice of differ-
ent populations and health care systems.
Treatment of patients with chronic diseases will be one
of the main challenges of medicine in the future because
they are very often influenced by psychosomatic or biop-
sychic factors. Additionally, the psychosomatic origins of
many diseases are of interest and important to broader
scientific discussion. In a historical view we know that,
the patient-physician relationship [1] is especially impor-
tant for every medical/therapeutic action for patients
with chronic diseases. This also is supported by the new
placebo literature that explains how the thinking, expec-
tations, and trust of patients in the treatment procedures
and in the person of the physician is essential for a posi-
tive response, e.g. reducing of symptoms or influencing
the healing, of the disease [2,3]. This paper presents an
overview of different origins, mechanism, and symptoms
necessary for understanding new and different interven-
tions that include a psychosomatic view.
Important stressors and risk factors for developing a
chronic disease, worsening it, or increasing their
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the ethiopathogenesis of disease, psychological media-
tors, behavioural risk factors, the severity of the disease
itself, and their somatic, psychological and sociological
effects (Table 1).
Thus, in a psychosomatic therapeutic intervention
there are very different targets, such as psychological
symptoms, personality traits, attitudes toward disease
and life, risk behaviour, and social isolation and as bio-
logical targets the change of autonomic imbalance and of
the effects of the psycho-endocrinological or psycho-
immunological stress responses (Table 2).
However, there are also different psychosomatic mea-
sures that influence the individual biological, psychologi-
cal and sociological targets (Table 3). To date, there are
no convincing studies that demonstrate which treatment
regimen is helpful for which target in which chronic dis-
ease. There are many reports of experiences in the clini-
cal field related to psychosomatic therapeutic support
for chronic diseases [4], but in this field the main work
lays in front of us. Methodological questions have arisen
as to which direction we should take to make the next
steps of research. Linda Powell and coworkers [5] gave
interesting advice here, comparing the situation with the
pharmacological field: Phase 1, phase 2, and phase 3 stu-
dies are all helpful and necessary for different tasks in
related to this situation of medicine (Table 4). There is
a need to give different answer to different questions in
the field of psychosomatic and behavioral medicine.
This volume of BioPsychoSocial Medicine will present
different studies from the clinical field in the sense of
phase 2 studies. Trials of representative chronic diseases
using mostly unselected patient samples and special
issues, but no randomized controlled trials (RCT) will
be reported. Although scientific, clinical, and social
medical discussion is important, phase 3 studies give
proof of only one very specific and limited treatment
effect in one patient group, which does not accurately
present the clinical reality and complexity. The floor is
open for more phase 1 and phase 2 studies:
1. Some authors focus their intervention on only one
important factor - on worrying as a predictor for the
development of cardiovascular diseases, such as essential
hypertension [6]. This study is an example for focusing
a psycho social intervention on a single psychic variable
argued as responsible for the development of disease.
Here the technique of the behavioral intervention seems
very simple but successful in targeting the important
influencing factor, such as depression in studies with
coronary artery disease [7].
2. Another important aspect is the kind and dosage of
drugs used in a psychosomatic therapy. Is it sufficient to
treat depression or anxiety in a chronic disease with psy-
chopharmaceuticals alone, or it is necessary to apply
additional psychosocial interventions. If so, what amount
of psychotherapy is helpful: 10 minutes more conversa-
tion with the physician compared to therapy as usual
(TAU), or one, two or fifteen hours more than TAU?
Moreover, which psychotherapeutic strategy is necessary:
relaxation, cognitive, behavioral, or insight therapy, and
in which therapeutic setting: individual therapy, group
therapy, or a combined therapeutic program in an outpa-
tient or inpatient setting? The basis for all these interac-
tions is a trustful relationship between the patient and
therapist, which means that the therapist has to acknowl-
edge the needs and low self esteem of patients and to
give hope and trust in the future through professional
activity and good relations with the family and friends, all
Table 1 Bio psycho social origins of chronic diseases (e.g coronary heart disease, bronchial asthma, rheumatoid
arthritis, inflammatory bowel disease, essential hypertension, atopic dermatitis, diabetes, cancer and others; modified
after Orth-Gomér et al 1997)
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7
Psychological
mediators
depression anxiety hostility denial type A type C type D
Behavioral risk
factors
smoking sedentary life
style
poor nutrition alcohol consumption suicidal
behavior
no care for the
own person
over active
Pathological
mechanism
genetic autonomic im-
balance
psycho-
immunological path-
ways
psycho-
endocrinological path-
ways
inflammation lipids/
glucose
coagulation
Severity of
disease
somatic bodily
complaints
bodily
limitations
pain
psychological psychic
symptoms
chronic
depression
suicidal tenden-cies chronic anxiety too many
doctor visits
too many drugs social
inhibition
sociological low social
functioning
social isolation unable to work low income high
treatment
costs
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Orth-Gomér showed the usefulness of these activities in
their gender segregated groups. Men and women with
coronary heart disease seem to do better if they are kept
apart in psychotherapeutic groups. It is very impressive
to see the way in which such a program of intensive psy-
cho social intervention can influence the psychic and
somatic condition of patients.
3. Therapeutic activity depends not only on the devel-
oped health care situation of an individual country, such
as Japan, Germany or the US, but also on the research
results on special diseases worldwide. Standardization has
been done in evidence based medicine (EBM) according
psychosocial interventions for different diseases. Great
differences in international guideline can be found, i.e. in
anorexia nervosa therapeutic measurements between the
NICE guidelines of the UK and the German S3 guidelines
for eating disorders [8,9].
3. What is the target of treatment for different diseases:
Symptom reduction, healing, or limiting progression to the
worst case - the death of patients with anorexia nervosa
[10]. After a complex, high intensity inpatient therapy, it is
important to analyse the conditions that foster a bad
outcome and determine the psychosocial factors and
psychotherapeutic interventions that improve the prospects
for a better long term outcome. In this issue, Laurence
Erdur et al present predictors for a dead end after intensive
inpatient psychotherapy of Anorexia nervosa.
Table 2 Different psychological, biological and sociological targets forchronic diseases
Targets of
psychosomatic therapy
Target 1 Target 2 Target 3 Target 4 Target 5
Psychological
reducing
symptoms
depression anxiety hostility pain
changing
personality
traits
self esteem salutogenesis type A type C type D
changing attitudes to disease
and life
coping
abilities
Behavioral
changing
behavior
adaption of
illness
behavior
smoking,
alcohol
eating habits
Vegetables and
Low fat
physical
activity
Sociological
Gaining social
support
social
activities
going to
work
better relationship with part
ner/spouse
better
relationship to
other family
members
better
relation
ship to
friends
a.
neighbours
Biological
targets
harmonize the
autonomic
imbalance
influence
the psycho-
endocrino-
logical
stress response
influence
the psychoen-
docrinological
stress response
-cortisol, catecholamine axis)
influence
pathogenic
psychoin-
flammatory
mechanism
influence
pathogenic psycho-
immunologic
mechanism
influence
cerebral regulation
of
the stress
response
Biological
Targets:
Disease
oriented
measurements
asthma:
reduce tendencies
for
attacks of
hyperventi
lation
diabetes:
reduce phases of hyper
and hypo
glycemia
atopic dermatitis: reduce
phases of
cratching
essential hy-
Pretension:
handel
hypertensive
crisis after
emotional
activation
Disease orient-
ted management
information
about disease
make regulatory doctor
visits
behaviour
according disease management
needs
take regulatory
drugs
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dence based medicine and the importance of randomized
controlled trials (RCT) for findings in psychosomatic
medicine - the only argument for what counts in the dis-
cussion of the somatic disciplines [11]. But, we also have
also to differentiate between “phase 2” and “phase 3” stu-
dies in a pharmacological sense [4]. In this situation, we
need many phase 2 studies to show the effectiveness and
not only the efficacy of a targeted psychosocial interven-
tion in a special situation for a special patient group.
Comparative effectiveness research is an important strat-
egy for solving these methodological issues [12].
This seems also true in the complex field of patients
with pain disorders. Bernd Bergander and collegues show
in their article the situation the conditions and the suc-
cess of a complex inpatient treatment program for these
patients. They demonstratedt h a tt h e r ea r ed i f f e r e n c e s
between older and younger patients in the concept and
Table 3 Different psychological, biological and sociological therapeutic interventions for chronic diseases by general
practitioners, medical specialists and psychotherapists
Psychosoma-
tic therapy
Individual,
group insight
therapy,
Individual,
group CBT
Relaxa-
tion
Family,
social
therapy
Mentali-
sation
Psycho-
pharma
ceuticals
Other
drug
therapy
Psychological
Reducing
of symptoms
+++ +++ ++ + ++ +
Changing
personality
traits
+++ ++
Changing atti-
tudes to di-
sease and life
++ ++
Behavioral
changing
behavior
+ +++ physical
training
groups
++
Sociological
Gaining social
support
++ ++ +++
Biological
targets
Harmonize the
autonomic
imbalance
+ + +++
Influence
pathogenic
psycho-inflam-
matory
mechanism
+? +? ++? ? ? ? ?
Influence
cerebral re-
gulation of
the stress
response
? ? ? ? ++? ? ?
Disease
oriented
measurements
+ ++ ++ + +++
Disease orient-
ted management
+++
Table 4 Psychosomatic/behavioural research strategies
for treatment trials in chronic diseases (according to
L. Powell (2010)
Activities Targets
1. Identify mechanism and pacemaker of chronic diseases
2. Evaluate effects of different psychosomatic therapeutic
interventions
in chronic diseases in a regular clinical setting
(phase 1 and phase 2 studies)
3. Evaluate therapeutic effects in different diseases in randomized
controlled trials (RCT, phase 3 studies)
4. Bring
back
the forthcomings of RCT’s in the clinical field. Make
observational studies for all unselected patients
5. Specify different targets of bio psycho social medicine in chronic
diseases and make again phase 1 and phase 2
psychosocial
intervention studies for it
6. Compare different therapeutic strategies/interventions for
different targets in one chronic disease
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between physician and patient, there is a need to under-
stand the individual condition of patients, but it is also
an advantage if the physician has good experience in
treating this kind of patients over a long period of time
and in a somatic and psychological way.
From psycho analytic studies we know that the attach-
ment style of an individual - developed since childhood-
is important to the success of a good patient relationship:
Sybille Kiesewetter et al showed in their study of patients
with obesity the importance of this factor and the helping
alliance between patient and therapist in a weight loss
program designed to promote a positive change of the
body mass index of these patients.
Who is responsible for psychosocial intervention: The
physician, the internist, the psychotherapist, the psycholo-
gist, the nurse, or the social worker? There is no doubt
that every person involved in a psycho social intervention
should be well versed in the kind of somatic/pharmacolo-
gical therapy for this disease. He/she should additionally
have good communicative ability, a cooperative attach-
ment style, and the capability of understanding patients as
biographical, psychological, and sociological beings. This
seems to me a non-negligable basis of a psycho social
intervention for chronic disease patients. Additionally, the
therapist needs knowledge about the risk factors that
influence the beginning, course, and end stages of disease
as well as the ability to change the thinking and behavior
of the patient.
One question remains: All four studies in this volume
are without a control group, e.g. phase 2 studies. They
show efficiacy in a clinical setting without special selection
of patients using standardized measurements and meth-
ods. Naturally, there is a need for additional randomized
controlled trials, but to date the medical field is very het-
erogenous in regard to all diseases that are influenced by
psycho social factors. Gender, age, severity, and duration
of disease and the severity of psychiatric co-morbidity as
well as drug intake are additional factors that influence the
disease condition and the kind of psychosomatic somato/
psychic mechanism. The field is open for different psycho
social interventions on different levels for different dis-
eases, controlling for all the factors mentioned above [13].
As a first step, we must show the effectiveness of such
interventions for several diseases - epidemiological and
socio medically important and influenced by psychoso-
matic factors. If we achieve good and impressive results, it
will make it possible to change the medical practice in
Japan, and all over the world [14]. This volume of BPSMe-
dicine presents four studies to show examples of the ways
we can to go in preparing and conducting psycho social
medical interventions.
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